rs61742891
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000340096.11(OFD1):āc.2052C>Gā(p.Ser684=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000942 in 1,167,496 control chromosomes in the GnomAD database, including 7 homozygotes. There are 298 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. S684S) has been classified as Benign.
Frequency
Consequence
ENST00000340096.11 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OFD1 | NM_003611.3 | c.2052C>G | p.Ser684= | synonymous_variant | 16/23 | ENST00000340096.11 | NP_003602.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OFD1 | ENST00000340096.11 | c.2052C>G | p.Ser684= | synonymous_variant | 16/23 | 1 | NM_003611.3 | ENSP00000344314 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00511 AC: 572AN: 111833Hom.: 5 Cov.: 23 AF XY: 0.00427 AC XY: 145AN XY: 33991
GnomAD3 exomes AF: 0.00170 AC: 248AN: 146019Hom.: 3 AF XY: 0.00116 AC XY: 56AN XY: 48201
GnomAD4 exome AF: 0.000500 AC: 528AN: 1055609Hom.: 2 Cov.: 31 AF XY: 0.000448 AC XY: 153AN XY: 341475
GnomAD4 genome AF: 0.00511 AC: 572AN: 111887Hom.: 5 Cov.: 23 AF XY: 0.00426 AC XY: 145AN XY: 34055
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 17, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 28, 2014 | - - |
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Familial aplasia of the vermis;C1510460:Orofaciodigital syndrome I Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at